Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Follow-up Repeat broad labs after 8-12 weeks if systemic use continues or symptoms change
In addition, intranasal foralumab is currently being studied in a Phase 2a, randomized, double-blind, placebo-controlled, multicenter, dose-ranging trial in patients with non-active secondary progressive multiple sclerosis (NCT06292923)
History of hormone-sensitive conditions As a precaution, until more human data is available
Check the Certificate of Analysis (COA) for: Identity confirmation (MS data matching expected molecular weight) HPLC purity (greater than 98% is recommended for reliable research work) Fill weight (the actual mass of lyophilized peptide in the vial, which may differ slightly from the nominal amount) Expiration or retest date Using the fill weight from the COA rather than assuming the labeled amount ensures your concentration calculations are accurate
They can weigh the potential risks and benefits of doing so, and together, you can come up with the best treatment plan to help you reach your weight loss goals
Can I use laxatives long-term whilst taking GLP-1 medications
